Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Chad Morris to Smoking Cessation

This is a "connection" page, showing publications Chad Morris has written about Smoking Cessation.

 
Connection Strength
 
 
 
3.049
 
  1. Morris CD, Lukowski AV, Vargas-Belcher RA, Ylioja TE, Nash CM, Bailey LA. Quitline Programs Tailored for Mental Health: Initial Outcomes and Feasibility. Am J Prev Med. 2021 03; 60(3 Suppl 2):S163-S171.
    View in: PubMed
    Score: 0.534
  2. Gordon L, Modayil MV, Pavlik J, Morris CD. Collaboration with behavioral health care facilities to implement systemwide tobacco control policies--California, 2012. Prev Chronic Dis. 2015 Feb 05; 12:E13.
    View in: PubMed
    Score: 0.350
  3. Morris CD, Burns EK, Waxmonsky JA, Levinson AH. Smoking cessation behaviors among persons with psychiatric diagnoses: results from a population-level state survey. Drug Alcohol Depend. 2014 Mar 01; 136:63-8.
    View in: PubMed
    Score: 0.325
  4. Morris CD, Waxmonsky JA, May MG, Tinkelman DG, Dickinson M, Giese AA. Smoking reduction for persons with mental illnesses: 6-month results from community-based interventions. Community Ment Health J. 2011 Dec; 47(6):694-702.
    View in: PubMed
    Score: 0.270
  5. Schroeder SA, Morris CD. Confronting a neglected epidemic: tobacco cessation for persons with mental illnesses and substance abuse problems. Annu Rev Public Health. 2010; 31:297-314 1p following 314.
    View in: PubMed
    Score: 0.246
  6. Morris CD, Waxmonsky JA, May MG, Giese AA. What do persons with mental illnesses need to quit smoking? Mental health consumer and provider perspectives. Psychiatr Rehabil J. 2009; 32(4):276-84.
    View in: PubMed
    Score: 0.230
  7. Kypriotakis G, Cinciripini PM, Green CE, Lawrence D, Anthenelli RM, Minnix JA, Beneventi D, Morris C, Karam-Hage M, Blalock JA. Effects of Varenicline, Bupropion, Nicotine Patch, and Placebo on Treating Smoking Among Persons With Current or Past Major Depressive Disorder: Secondary Analysis of a Double-Blind, Randomized, Placebo-Controlled Trial. Am J Psychiatry. 2025 Feb 01; 182(2):174-186.
    View in: PubMed
    Score: 0.173
  8. Gorrilla AA, Kaye JT, Pavlik J, Bonniot C, Vijayaraghavan M, Conner KL, Morris CD. A Call for Health Equity in Tobacco Control and Treatment for the Justice-Involved Population. Am J Prev Med. 2024 Oct; 67(4):631-636.
    View in: PubMed
    Score: 0.167
  9. Cinciripini PM, Kypriotakis G, Green C, Lawrence D, Anthenelli RM, Minnix J, Blalock JA, Beneventi D, Morris C, Karam-Hage M. The effects of varenicline, bupropion, nicotine patch, and placebo on smoking cessation among smokers with major depression: A randomized clinical trial. Depress Anxiety. 2022 05; 39(5):429-440.
    View in: PubMed
    Score: 0.145
  10. Garver-Apgar C, Young S, Howard B, Udochi B, Morris C. Effects of a Statewide Tobacco Cessation Program Among Individuals Involved With Arkansas Community Correction. J Correct Health Care. 2017 Jul; 23(3):259-270.
    View in: PubMed
    Score: 0.103
  11. Richey R, Garver-Apgar C, Martin L, Morris C, Morris C. Tobacco-Free Policy Outcomes for an Inpatient Substance Abuse Treatment Center. Health Promot Pract. 2017 07; 18(4):554-560.
    View in: PubMed
    Score: 0.100
  12. Lukowski AV, Young SE, Morris CD, Tinkelman D. Characteristics of American Indian/Alaskan Native Quitline Callers Across 14 States. Nicotine Tob Res. 2016 11; 18(11):2124-2129.
    View in: PubMed
    Score: 0.096
  13. Lukowski AV, Morris CD, Young SE, Tinkelman D. Quitline Outcomes for Smokers in 6 States: Rates of Successful Quitting Vary by Mental Health Status. Nicotine Tob Res. 2015 Aug; 17(8):924-30.
    View in: PubMed
    Score: 0.091
  14. Anthenelli RM, Morris C, Ramey TS, Dubrava SJ, Tsilkos K, Russ C, Yunis C. Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial. Ann Intern Med. 2013 Sep 17; 159(6):390-400.
    View in: PubMed
    Score: 0.080
  15. Williams JM, Anthenelli RM, Morris CD, Treadow J, Thompson JR, Yunis C, George TP. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry. 2012 May; 73(5):654-60.
    View in: PubMed
    Score: 0.072
  16. DeHay T, Morris C, May MG, Devine K, Waxmonsky J. Tobacco use in youth with mental illnesses. J Behav Med. 2012 Apr; 35(2):139-48.
    View in: PubMed
    Score: 0.067
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)